CVRx, Inc.
CVRX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001235912
In the last 90 days, CVRx, Inc. insiders filed 1 open-market purchase and 1 sale; 87 institutions reported holding it in 13F filings for Q2 2026, worth $78.7M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding CVRx, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 39 | 39 | 0 |
| Shares | 10.9M | 10.5M | −360.0K (−3.3%) |
| Value | $65.5M | $98.2M | +$32.8M (+50.1%) |
New holders (8)
Institutions that held CVRx, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 615,159 | $5.74M | 0.00% |
| Raymond James Financial Services Advisors, Inc. | 40,790 | $381.0K | 0.00% |
| RBF Capital, LLC | 39,641 | $370.0K | 0.03% |
| G2 Investment Partners Management LLC | 38,358 | $358.0K | 0.11% |
| Federated Hermes, Inc. | 14,000 | $131.0K | 0.00% |
| Accredited Investors Inc. | 11,985 | $112.0K | 0.01% |
| Tower Research Capital LLC (TRC) | 9,382 | $88.0K | 0.00% |
| Simplex Trading, LLC | 296 | $2.00K | 0.00% |
Sold out (8)
Institutions that held CVRx, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Price T Rowe Associates Inc | 618,649 | $3.72M |
| Prelude Capital Management, LLC | 17,899 | $108.0K |
| Cubist Systematic Strategies, LLC | 15,294 | $92.0K |
| Captrust Financial Advisors | 590 | $4.00K |
| New York State Common Retirement Fund | 106 | $1.00K |
| Citigroup Inc | 110 | $1.00K |
| Credit Suisse AG | 6 | $0 |
| Ellevest, Inc. | 16 | $0 |